标题
N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes
作者
关键词
-
出版物
CHEMICAL COMMUNICATIONS
Volume 51, Issue 8, Pages 1410-1413
出版商
Royal Society of Chemistry (RSC)
发表日期
2014-10-16
DOI
10.1039/c4cc07284g
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mode of cell death induced by the HSP90 inhibitor 17-AAG (tanespimycin) is dependent on the expression of pro-apoptotic BAX
- (2015) Marissa V Powers et al. Oncotarget
- Chemically Accessible Hsp90 Inhibitor That Does Not Induce a Heat Shock Response
- (2014) Yen Chin Koay et al. ACS Medicinal Chemistry Letters
- Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux
- (2013) Buddhini Samarasinghe et al. BIOCHEMICAL PHARMACOLOGY
- Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets
- (2013) Jeanette R. McConnell et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A heat shock protein 90 inhibitor that modulates the immunophilins and regulates hormone receptors without inducing the heat shock response
- (2013) Jeanette R. McConnell et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies
- (2013) Jonathan W Goldman et al. BMC CANCER
- A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer
- (2013) Shanu Modi et al. BREAST CANCER RESEARCH AND TREATMENT
- Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells
- (2013) Nishant Gandhi et al. CANCER BIOLOGY & THERAPY
- HSF1 in Translation
- (2013) Emmanuel de Billy et al. CANCER CELL
- Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology
- (2013) Paul Workman et al. CURRENT OPINION IN PHARMACOLOGY
- Drugging cancer genomes
- (2013) Paul Workman et al. NATURE REVIEWS DRUG DISCOVERY
- Personalized Medicine: Patient-Predictive Panel Power
- (2012) Paul Workman et al. CANCER CELL
- HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers
- (2012) Marc L. Mendillo et al. CELL
- Protein Kinase CK2 Protects Multiple Myeloma Cells from ER Stress-Induced Apoptosis and from the Cytotoxic Effect of HSP90 Inhibition through Regulation of the Unfolded Protein Response
- (2012) S. Manni et al. CLINICAL CANCER RESEARCH
- Macrocycles That Inhibit the Binding between Heat Shock Protein 90 and TPR-Containing Proteins
- (2011) Veronica C. Ardi et al. ACS Chemical Biology
- Regulation of HSF1 Function in the Heat Stress Response: Implications in Aging and Disease
- (2011) Julius Anckar et al. Annual Review of Biochemistry
- Synthesis and evaluation of biotinylated sansalvamide A analogs and their modulation of Hsp90
- (2011) Joseph B. Kunicki et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A small molecule that preferentially binds the closed conformation of Hsp90
- (2011) Leslie D. Alexander et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status - consequences and potentials for pharmacological intervention
- (2011) Håkon Reikvam et al. BRITISH JOURNAL OF HAEMATOLOGY
- Targeting HSP70: The second potentially druggable heat shock protein and molecular chaperone?
- (2011) Marissa V. Powers et al. CELL CYCLE
- Design and synthesis of Hsp90 inhibitors: Exploring the SAR of Sansalvamide A derivatives
- (2010) Robert P. Sellers et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Mechanistic Studies of Sansalvamide A-Amide: An Allosteric Modulator of Hsp90
- (2010) Robert C. Vasko et al. ACS Medicinal Chemistry Letters
- Hsp90 as a Gatekeeper of Tumor Angiogenesis: Clinical Promise and Potential Pitfalls
- (2010) J. E. Bohonowych et al. Journal of Oncology
- Targeting HSP90 for cancer therapy
- (2009) D Mahalingam et al. BRITISH JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started